VIA Pharmaceuticals, Inc. (VIAP)
Develops drug treatments for heart disease, high cholesterol, diabetes, and related metabolic disorders.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
VIAP is trading near its 52-week high, sitting above both its 50- and 200-day moving averages, suggesting strength in its recent trend. Analyst coverage appears minimal, so detailed consensus ratings are unavailable. The stock's current positioning reflects upward momentum within its recent trading range.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$10,279
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—